Modafinil, a wakefulness-selling agent, has garnered vital attention since its introduction in the late nineties. Initially developed to deal with narcolepsy, a sleep disorder characterized by extreme daytime sleepiness, modafinil has since been acknowledged for its potential cognitive-enhancing results and is steadily discussed within the context of off-label use, particularly among college students, professionals, and…